This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.

United Kingdom | EN-GB

Cortex - Life Sciences Insights

Fredrika Allard

Head of Life Sciences, Sweden, DLA Piper

Stockholm , Sweden

fredrika.allard@dlapiper.com

Jan 30, 2023

Swedish government proposes fines between SEK 25k - 100m (approx. EUR 2,500 – 10 million) for late backorders by pharmaceutical companies

By Fredrika Allard

The Swedish government has on 24 January 2023 proposed a bill with actions aimed at improving the availability of medicines. The bill...

Jun 28, 2022

Sweden to implement a new Biobanks Act

By Fredrika Allard

The Swedish government has decided to implement a new Biobanks Act, which is suggested to enter into force on 1 July 2023. The current...

DLA Piper is a global law firm operating through various separate and distinct legal entities. For further information about these entities and DLA Piper's structure, please refer to the Legal Notices page of this website. All rights reserved. Attorney advertising.